Market revenue in 2023 | USD 5,456.0 million |
Market revenue in 2030 | USD 8,513.3 million |
Growth rate | 6.6% (CAGR from 2023 to 2030) |
Largest segment | Transdermal patches |
Fastest growing segment | Infusion Pumps |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Photodynamic Therapy Devices, Transdermal Patches, Wound Care Products, Infusion Pumps, Orthopedic Combination Products, Drug Eluting Stents, Inhalers, Antimicrobial Catheters |
Key market players worldwide | Abbott Laboratories, Terumo Corp, Stryker Corp, Viatris Inc, Medtronic PLC, Boston Scientific Corp, Novartis AG ADR, Becton Dickinson & Co, Teleflex Inc, W L Gore & Associates |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug device combination products market will help companies and investors design strategic landscapes.
Transdermal patches was the largest segment with a revenue share of 23.15% in 2023. Horizon Databook has segmented the Latin America drug device combination products market based on photodynamic therapy devices, transdermal patches, wound care products, infusion pumps, orthopedic combination products, drug eluting stents, inhalers, antimicrobial catheters covering the revenue growth of each sub-segment from 2018 to 2030.
Latin America drug-device combination products market is primarily driven by Brazil, Mexico, and Argentina. Growing investments by market players in the region, proximity to North America, and free trade agreements with major countries such as the U.S., Canada, Japan, & several European countries are anticipated to boost the Latin America drug-device combination products market during the forecast period.
The Latin America drug-device combination products market is primarily driven by the rise in the prevalence of chronic diseases and a rapidly aging population, which is increasing the number of surgical procedures related to heart and lung transplants. Drug-device combination products provide an effective treatment option for these diseases, as they offer targeted delivery of medication to specific areas of the body.
In addition, the aging population in Latin America is increasing, which is leading to a higher demand for healthcare services & products. Drug-device combination products can help to improve patient outcomes and reduce hospital stays, making them an attractive option for healthcare providers.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America drug device combination products market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America drug device combination products market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account